SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-16-000724
Filing Date
2016-02-12
Accepted
2016-02-11 17:38:03
Documents
1
Group Members
ECOR1 CAPITAL FUND QUALIFIED, L.P.OLEG NODELMAN

Document Format Files

Seq Description Document Type Size
1 kindredbiosch13amd2.htm SC 13G/A 37243
  Complete submission text file 0000935836-16-000724.txt   38788
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Subject) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87768 | Film No.: 161413067
SIC: 2834 Pharmaceutical Preparations

Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A